$XPEL

XPEL (XPEL) Q3 2025 Earnings Call Transcript

Image source: The Motley Fool.Wednesday, Nov. 5, 2025, at 11 a.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading ...

Original reporting
Motley Fool · Motley Fool Transcribing, https://www.facebook.com/themotleyfool/
Published Nov 6, 2025, 1:32 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2025, 2:30 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
XPEL (XPEL) Q3 2025 Earnings Call Transcript — source image
Decision brief

The 30-second read

$XPELBullishMed
01

Why it matters

Positive earnings surprise and strategic initiatives suggest potential for short-term stock appreciation, though sector volatility warrants caution.

02

Market read

The earnings call reinforces XPEL's position within the automotive aftermarket sector, with potential ripple effects on related stocks.

03

What to watch

Potential margin pressures from raw material costs and integration risks from recent acquisitions could temper gains.

Relevance 6/10Timing: Immediate (within 1-2 days post-earnings call)

Background

XPEL reported strong Q3 2025 earnings driven by increased demand in the automotive protective film market, expanding its customer base and launching new product lines.

Company-level read

Ticker impact

$XPELBullishHigh confidence
Context

Primary focus of the earnings call transcript indicates significant relevance.

Expected impact

Moderate upward movement expected in the short term (~3-5%), contingent on broader market conditions.

Evidence & confidence

Strong earnings performance combined with positive outlooks and industry tailwinds support an optimistic short-term price movement.

Market effects

Potential positive impact on automotive supply chain stocks due to increased demand for protective films and coatings.

Primarily affecting North American markets, where XPEL has significant operations.

Limited; impact mostly confined to regional automotive and manufacturing sectors.

Counterpoint

If broader economic indicators weaken or supply chain disruptions occur, XPEL's stock may underperform despite earnings beat.

Key entities

  • XPEL Inc.

    Manufacturer specializing in protective films and coatings for automotive and other industries.

  • Automotive Industry

    Industry benefiting from increased demand for vehicle protection and customization.

Related articles

$XPELMedAI 8/10

XPEL (XPEL) Q2 2026 Earnings Call Transcript

XPEL, Inc. (XPEL) reported Q2 2026 revenue of $143.1 million, up 14.7% year over year, with U.S. revenue at $78.6 million (+11.7%) and China revenue at $15.9 million (+106.7%). Gross margin rose to 44.1%. Non-GAAP EPS was $0.68. Q3 revenue guidance is $137 million to $139 million.

$XPELMed

XPEL, Inc. Q2 2026 Earnings Call Summary

XPEL reported record Q2 2026 revenue of $143.1 million, up 14.7%, including about $2 million of pull-ahead sales tied to expected Q3 price increases. Gross margin rose to 44.1%. Q3 revenue guidance is $137 million to $139 million. Management cited SKU reductions, margin step-ups from new manufacturing, and a $110 million facilities investment.

$XPELMed

XPEL Reports Record Revenue of $143.1 million; Revenue Growth of 14.7% in Second Quarter 2026

XPEL, Inc. (XPEL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Ex. 99.1 XPEL Reports Record Revenue of $143.1 million; Revenue Growth of 14.7% in Second Quarter 2026 San Antonio, TX – August 5, 2026 – XPEL, Inc. (Nasdaq: XPEL) (the "Company"), a global provider of protective films and coatings, announced consolidated results 1 for the second

$BAMed

Reuters Reports Boeing 777F Halt in Vaero Dispute

Boeing's 777 Freighter production was halted for nearly two months due to a dispute with supplier Vaero, according to Reuters. The disruption also affected 767 output, including freighters and KC-46 tankers. Boeing alleged daily costs of up to $6.5m. Emirates ordered five additional 777Fs in October 2024. Boeing declined to comment, and Vaero and FedEx did not respond to requests.

$BMYMed

Tempus Sets $55 Million Ceiling for Pathos Neurology Data Contract

Tempus AI signed a five-year neurology data deal with Pathos AI, potentially worth $55 million. Tempus will deliver up to 500,000 records, with Pathos paying $100 per record. Bristol Myers Squibb gains nonexclusive Foundry access and three-year exclusive rights for neuroscience development. Tempus also has a $137.5 million oncology deal with BMS, totaling $192.5 million if both deals reach full value.